Vol. 1 — January-February 2013

• Editorial
  

  Francesca Mallamaci¹

  (1) Editor in Chief

• Geographic information systems and chronic kidney disease: racial disparities, rural residence and forecasting
  

  Rudolph A. Rodriguez¹, John R. Hotchkiss², Ann M. O’Hare¹

  (1) University of Washington and Veterans Affairs Puget Sound Healthcare System, Seattle, Washington - USA
  (2) University of Pittsburgh and Veterans Engineering Resource Center, Pittsburgh, Pennsylvania - USA

• Estimating the influence of physicians on the underuse of drugs in diabetic nephropathy in Taiwan
  

  Li-Ying Huang^1,2, Hseng-Long Yeh^3,4, Syi Su⁵, Ting-Chung Wang⁶, Jun Yi Hsieh⁷

  (1) Division of Health Technology Assessment, Center for Drug Evaluation, Taipei - Taiwan
  (2) and Institute of Health Care Organization Administration, College of Public Health, National Taiwan University, Taipei - Taiwan
  (3) Department of Cardiology, Sijhih Cathay General Hospital, Taipei - Taiwan
  (4) and School of Public Health, College of Public Health and Nutrition, Taipei Medical University, Taipei - Taiwan
  (5) Graduate Institute of Health Care Organization Administration, College of Public Health, National Taiwan University, Taipei - Taiwan
  (6) Departments of Medical Research, Cathay General Hospital, Taipei - Taiwan
  (7) Department of Social and Public Affairs, Taipei Municipal University of Education, Taipei - Taiwan

• Retention and growth of urinary stones: insights from imaging
  

  James C. Jr Williams¹, James A. McAteer¹

  (1) Indiana University School of Medicine, Indianapolis, Indiana - USA

• Acute kidney injury in patients undergoing cardiac surgery
  

  Giuseppe Coppolino¹, Piera Presta¹, Laura Saturno¹, Giorgio Fuiano¹

  (1) Nephrology Unit, Magna Graecia University, Catanzaro - Italy

• Strategies to reduce the incidence of chronic kidney disease in children: time for action
  

  Farahnak Assadi¹

  (1) Department of Pediatrics, Section of Nephrology, Rush University Medical College, Chicago, Illinois - USA

• The debate between gadolinium versus erythropoietin in a renal transplant patient with nephrogenic systemic fibrosis
  

  Pantea Hashemi¹, Bahram Sina², William Rietkerk¹, Bijan Safai¹

  (1) Department of Dermatology, New York Medical College, New York, NY - USA
  (2) Department of Dermatology, University of Maryland Medical Center, Baltimore, MD - USA

• Metformin in patients with chronic kidney disease: strengths and weaknesses
  

  Ana Rocha¹, Marta Almeida², Josefina Santos¹, André Carvalho²

  (1) Nephrology Department, Centro Hospitalar do Porto, Porto - Portugal
  (2) Endocrinology Department, Centro Hospitalar do Porto, Porto - Portugal

• The management of hyponatremia in HIV disease
  

  Madhav C. Menon¹, Amarinder S. Garcha², Apurv Khanna²

  (1) Department of Medicine, Mount Sinai School of Medicine, New York, NY - USA
  (2) Department of Medicine, SUNY Upstate Medical University, Syracuse, NY - USA

• Osteoporosis and adynamic bone in chronic kidney disease
  

  Jorge B. Cannata-Andía¹, Minerva Rodriguez García², Carlos Gómez Alonso¹

  (1) Bone and Mineral Research Unit, Hospital Universitario Central de Asturias, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, University of Oviedo, Oviedo, Asturias - Spain
  (2) Nephrology Service, Hospital Universitario Central de Asturias, Instituto Reina Sofía de Investigación, REDinREN del ISCIII, University of Oviedo, Oviedo, Asturias - Spain

• Assessing a nephrology-focused YouTube channel’s potential to educate health care providers
  

  Tejas Desai¹, Vivek Sanghani², Xiangming Fang³, Cynthia Christiano¹, Maria Ferris⁴

  (1) Division of Nephrology and Hypertension, East Carolina University, Greenville, North Carolina - USA
  (2) Department of Internal Medicine, Wake Forest University Medical Center, Winston-Salem, North Carolina - USA
  (3) Department of Biostatistics, East Carolina University, Greenville, North Carolina - USA
  (4) Division of Nephrology, University of North Carolina – Chapel Hill, Chapel Hill, North Carolina - USA

• IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine
  

  Claudio Pozzi^1,2, Simeone Andrulli¹, Antonello Pani³, Patrizia Scaini⁴, Dario Roccatello⁵, Giambattista Fogazzi⁶, Paola Pecchini⁷, Roberto Rustichelli⁸, Pietro Finocchiaro⁹, Lucia Del Vecchio¹, Francesco Locatelli¹

  (1) Department of Nephrology and Dialysis, A. Manzoni Hospital, Lecco - Italy
  (2) and Department of Nephrology and Dialysis, E. Bassini Hospital, Cinisello Balsamo, Milan - Italy
  (3) Department of Nephrology and Dialysis, G. Brotzu Hospital, Cagliari - Italy
  (4) Department of Nephrology and Dialysis, Spedali Civili, Brescia - Italy
  (5) Department of Nephrology and Dialysis, Center of Research on Immunopathology and Documentation on Rare Diseases, Turin - Italy
  (6) Department of Nephrology and Dialysis, Ospedale Maggiore IRCCS, Milan - Italy
  (7) Department of Nephrology and Dialysis, Istituti Ospitalieri, Cremona - Italy
  (8) Department of Nephrology and Dialysis, S. Maria Nuova Hospital, Reggio Emilia - Italy
  (9) Department of Nephrology and Dialysis, CNR-IBIM Hospital, Reggio Calabria - Italy

• Is an average of routine postdialysis blood pressure a good indicator of blood pressure control and cardiovascular risk?
  

  Philip R. Harvey¹, Ashley Holt², Johann Nicholas³, Indranil Dasgupta⁴

  (1) Department of Medicine, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, West Midlands - UK
  (2) Department of Medicine, University Hospital North Staffordshire NHS Trust, Stoke on Trent, Staffordshire - UK
  (3) Department of Nephrology, Royal Wolverhampton NHS Trust, Wolverhampton, West Midlands - UK
  (4) Department of Nephrology, Heart of England NHS Trust, Birmingham, West Midlands - UK

• Association of sleep disturbances with cognitive impairment and depression in maintenance hemodialysis patients
  

  Luke Rodriguez¹, Hocine Tighiouart², Tammy Scott², Kristina Lou², Lena Giang³, Eric Sorensen⁴, Daniel E. Weiner², Mark J. Sarnak²

  (1) Department of Biology, Cayey Campus, The University of Puerto Rico, Cayey - Puerto Rico
  (2) Tufts Medical Center and Tufts University School of Medicine, Boston, Massachusetts - USA
  (3) Brown University School of Public Health, Providence, Rhode Island - USA
  (4) University of California San Diego School of Medicine, San Diego, California - USA

• Associations among chronic kidney disease, high total p-cresylsulfate and major adverse cardiac events
  

  Chao-Ping Wang^1,2, Li-Fen Lu³, Teng-Hung Yu¹, Wei-Chin Hung¹, Cheng-An Chiu¹, Fu-Mei Chung¹, Chia-Chang Hsu⁴, Yung-Chuan Lu⁵, Yau-Jiunn Lee⁶, Jer-Yiing Houng⁷

  (1) Division of Cardiology, E-Da Hospital, I-Shou University, Kaohsiung - Taiwan
  (2) and Department of Medical Nutrition, Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung - Taiwan
  (3) Division of Cardiac Surgery, Department of Surgery, E-Da Hospital, I-Shou University, Kaohsiung - Taiwan
  (4) Division of Gastroenterology and Hepatology, E-Da Hospital, I-Shou University, Kaohsiung - Taiwan
  (5) Division of Endocrinology and Metabolism, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung - Taiwan
  (6) Lee’s Endocrinologic Clinic, Pingtung - Taiwan
  (7) Department of Medical Nutrition, Institute of Biotechnology and Chemical Engineering, I-Shou University, Kaohsiung - Taiwan

• Geographical variability of patient characteristics and treatment patterns affect outcomes for incident hemodialysis pat
  

  Alejandro Martin-Malo¹, Menelaos Papadimitriou², Joao Cruz³, Jesus Bustamante⁴, Dierik Verbeelen⁵, Alain Nony⁶, Raymond Vanholder⁷, Stefan H. Jacobson⁸, Jesus Montenegro⁹, Thierry Hannedouche¹⁰, Volker Wizemann¹¹, Francesco Locatelli¹², For the Membrane Permeability Outcome (MPO) Study Group*¹³

  (1) Department of Nephrology, University Hospital Reina Sofia, Cordoba - Spain
  (2) Department of Nephrology, Hippokration General Hospital, Thessaloniki - Greece
  (3) Fresenius Medical Care Dialysis Unit, Amadora - Portugal
  (4) University Clinic Hospital, Valladolid - Spain
  (5) University Hospital, Brussels - Belgium
  (6) General Hospital, Bourges - France
  (7) Department of Internal Medicine, Nephrology Section, University Hospital, Ghent - Belgium
  (8) Department of Nephrology, Danderyd University Hospital, Karolinska Institute, Stockholm - Sweden
  (9) General Hospital of Galdakao, Bilbao - Spain
  (10) Department of Nephrology, University Hospital, Strasbourg - France
  (11) Georg-Haas Dialysis Centre, Giessen - Germany
  (12) Department of Nephrology, Dialysis and Renal Transplantation, A. Manzoni Hospital, Lecco - Italy
  (13) * See the “Appendix” for a list of institutions and investigators

• Survival and factors predicting mortality in hemodialysis patients over 75 years old
  

  J. Sergio Oliva¹, Laura M. Roa^1,2, Alfonso Lara^1,3,4, Silvia Garrido¹, Mercedes Salgueira^1,3,4, Alfonso Palma^1,2, José A. Milán^1,3,4, Guillermo Martín-Reyes⁵

  (1) Biomedical Engineering Group, University of Seville, Seville - Spain
  (2) and Spanish Network Centre of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine, Zaragoza - Spain
  (3) Spanish Network Centre of Biomedical Research in Bioengineering, Biomaterials and Nanomedicine, Zaragoza - Spain
  (4) and Nephrology Service, University Hospital Virgen Macarena, Seville - Spain
  (5) Transplant Coordination Service of the Autonomous Community of Andalucía, Seville - Spain

• Soluble TWEAK level: is it a marker for cardiovascular disease in long-term hemodialysis patients?
  

  Ozkan Gungor¹, Fatih Kircelli¹, Gulay Asci¹, Juan Jesus Carrero², Erhan Tatar¹, Meltem Sezis Demirci¹, Süreyya Süha Özbek³, Naim Ceylan³, Huseyin Toz¹, Mehmet Ozkahya¹, Ercan Ok¹

  (1) Division of Nephrology, Ege University School of Medicine, Izmir - Turkey
  (2) Division of Renal Medicine, Centre for Gender Medicine and Centre for Molecular Medicine, Karolinska Institutet, Stockholm - Sweden
  (3) Division of Radiology, Ege University School of Medicine, Izmir - Turkey

• Relationship between sRAGE and eotaxin-3 with CRP in hypertensive patients at high cardiovascular risk
  

  Colomba Falcone^1,2, Maria Paola Buzzi^1,2, Sara Bozzini¹, Chiara Boiocchi¹, Angela D’Angelo¹, Sandra Schirinzi³, Jasmine Choi^4,5, Michael Ochan Kilama^4,5, Ciro Esposito⁶, Massimo Torreggiani⁶, Giuseppe Mancia⁷, TALENT Investigators

  (1) Interdepartmental Center of Research in Molecular Medicine (CIRMC), University of Pavia, Pavia - Italy
  (2) and Department of Cardiology, Istituto Città di Pavia, University Hospital, Pavia - Italy
  (3) Department of Cardiology, Istituto Città di Pavia, University Hospital, Pavia - Italy
  (4) Bayer Schering Pharma, Montville, New Jersey - USA
  (5) and Milan - Italy
  (6) Department of Nephrology, IRCCS Policlinico San Matteo, University of Pavia, Pavia - Italy
  (7) Department of Clinical Medicine and Prevention, University of Milano-Bicocca, Milan - Italy

• Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study
  

  Maïté Daroux^1,2, Milhad Shenouda¹, Jean-Louis Bacri³, Vincent Lemaitre³, Philippe Vanhille³, Pierre Bataille¹

  (1) Department of Nephrology, Doctor Duchenne Hospital, Boulogne-sur-Mer - France
  (2) and Department of Nephrology, Regional University Hospital of Lille, Lille - France
  (3) Department of Internal Medicine and Nephrology, Valenciennes Hospital, Valenciennes - France

• Dermatan sulfate: an alternative to unfractionated heparin for anticoagulation in hemodialysis patients
  

  Corrado Vitale¹, Silvia Berutti¹, Cristiana Bagnis¹, Giorgio Soragna¹, Paolo Gabella¹, Claudia Fruttero², Martino Marangella¹

  (1) Nephrology and Dialysis Unit, Ordine Mauriziano Hospital, Turin - Italy
  (2) Pharmacy Unit, Ordine Mauriziano Hospital, Turin - Italy

• Thyroid function tests in acute kidney injury
  

  Pedro Iglesias¹, Teresa Olea², Cristina Vega-Cabrera², Manuel Heras³, María A. Bajo², Gloria del Peso², María J. Arias⁴, Rafael Selgas², Juan J. Díez¹

  (1) Department of Endocrinology, Hospital Ramón y Cajal, Madrid - Spain
  (2) Department of Nephrology, Hospital La Paz, Madrid - Spain
  (3) Department of Nephrology, Hospital General, Segovia - Spain
  (4) Department of Biochemistry, Hospital La Paz, Madrid - Spain

• Variability of blood pressure in dialysis patients: a new marker of cardiovascular risk
  

  Biagio Di Iorio¹, Lucia Di Micco¹, Serena Torraca¹, Maria Luisa Sirico¹, Pasquale Guastaferro², Luigi Chiuchiolo³, Filippo Nigro², Antonietta De Blasio², Paolo Romano², Andrea Pota¹, Roberto Rubino⁴, Luigi Morrone⁵, Teodoro Lopez⁶, Francesco Gaetano Casino⁶

  (1) Division of Nephrology, “A. Landolfi” Hospital, Solofra, Avellino - Italy
  (2) Division of Nephrology, “G. Criscuoli” Hospital, Sant’Angelo dè Lombardi, Avellino - Italy
  (3) “Dialysis”, Avellino - Italy
  (4) Division of Nephrology, Ariano Irpino Hospital, Avellino - Italy
  (5) Division of Nephrology, “Rummo” Hospital, Benevento - Italy
  (6) Division of Nephrology, Matera Hospital, Matera - Italy

• Peritoneal phosphate removal varies by peritoneal dialysis regimen: an underestimated parameter of phosphate control
  

  Carlos Botelho^1,2, Anabela Rodrigues^1,2, Jose Carlos Oliveira³, António Cabrita^1,2

  (1) Department of Nephrology, CHP – Santo António Hospital, Porto - Portugal
  (2) and Institute of Biomedical Sciences Abel Salazar/Multidisciplinary Unit of Biomedical Investigation (ICBAS/UMIB), University of Porto, Porto - Portugal
  (3) Department of Clinical Pathology, CHP – Santo António Hospital, Porto - Portugal

• Differential proteomic analysis of renal tissue in mesangial proliferative glomerulonephritis using iTRAQ technology
  

  Weiguo Sui¹, Donge Tang², Tongxiang Zou¹, Guimian Zou¹, Jiejing Chen¹, Huan Li², Liping Li², Yuwen Hou², Haiyan Li², Yong Dai³

  (1) Central Laboratory of the 181st Hospital, Guangxi Key Laboratory of Metabolic Diseases Research, Guilin, Guangxi - PR China
  (2) The Life Science College, Guangxi Normal University, Guilin, Guangxi - PR China
  (3) Clinical Medical Research Center, The Second Clinical Medical College of Jinan University (Shenzhen People’s Hospital), Shenzhen, Guangdong - PR China

• Aldosterone mediates glomerular inflammation in experimental mesangial proliferative glomerulonephritis
  

  Danping Qin^1,2, Hiroyuki Morita^1,3, Kiyoko Inui¹, Hironori Tayama¹, Yoshihiko Inoue¹, Ashio Yoshimura¹

  (1) Division of Nephrology, Department of Medicine, Showa University Fujigaoka Hospital, Yokohama - Japan
  (2) and Division of Nephrology, Guangzhou Red Cross Hospital, Guangzhou - PR China
  (3) and Division of Nephrology and Rheumatology, Department of Internal Medicine, Aichi Medical University, Nagakute - Japan

• HNF-1beta mutation affects PKD2 and SOCS3 expression causing renal cysts and diabetes in MODY5 kindred
  

  Silvia Mancusi^1,2, Angela La Manna¹, Giulia Bellini³, Saverio Scianguetta¹, Domenico Roberti¹, Maddalena Casale¹, Francesca Rossi¹, Fulvio Della Ragione⁴, Silverio Perrotta¹

  (1) Department of Pediatrics, Second University of Naples, Naples - Italy
  (2) and Department of Experimental Medicine, Second University of Naples, Naples - Italy
  (3) Department of Experimental Medicine, Second University of Naples, Naples - Italy
  (4) Department of Biochemistry and Biophysics, Second University of Naples, Naples - Italy

• Role of TGF-beta1 in production of fibronectin in vascular smooth muscle cells cultured under high-phosphate conditions
  

  Ningning Wang¹, Xiaoyun Wang¹, Bin Sun¹, Ming Zeng¹, Changying Xing¹, Xiufen Zhao¹, Junwei Yang¹

  (1) Renal Division, Department of Internal Medicine, Nanjing Medical University, Affiliated First Hospital, Nanjing, Jiangsu Province - PR China

• Erythropoietin protects against cisplatin-induced nephrotoxicity by attenuating endoplasmic reticulum stress-induced apo
  

  Deyang Kong¹, Li Zhuo², Changlu Gao³, Suozhu Shi⁴, Nan Wang⁴, Zhiyong Huang⁴, Wenge Li², Lirong Hao¹

  (1) Department of Nephrology, 1st Affiliated Hospital of Harbin Medical University, Harbin - PR China
  (2) Department of Nephrology, China-Japan Friendship Hospital, Beijing - PR China
  (3) Department of Oncology, 4th Affiliated Hospital of Harbin Medical University, Harbin - PR China
  (4) Department of Nephrology, Chinese PLA General Hospital, State Key Laboratory of Kidney Disease, Beijing - PR China

• In vivo assessment of bacteriotherapy on acetaminophen-induced uremic rats
  

  Arpita Mandal¹, Koushik Das¹, Suchismita Roy¹, Keshab Ch. Mondal², Dilip Kumar Nandi^1,3

  (1) Department of Microbiology, Nutrition, and Human Physiology, Raja N.L. Khans Women’s college, Midnapore, West Bengal - India
  (2) Department of Microbiology, Vidyasagar University, Midnapore, West Bengal - India
  (3) and Dialysis Unit, Vidyasagar Institute of Health, Midnapore, West Bengal - India